PMC:7100515 / 17551-17798 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T148","span":{"begin":83,"end":88},"obj":"Body_part"}],"attributes":[{"id":"A148","pred":"fma_id","subj":"T148","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T141","span":{"begin":51,"end":59},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T394","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0001230"},{"id":"T395","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0037237"},{"id":"T396","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0050903"},{"id":"T397","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0054249"},{"id":"T398","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0054250"},{"id":"T399","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0054251"},{"id":"T400","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0054252"},{"id":"T401","span":{"begin":83,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T402","span":{"begin":114,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T403","span":{"begin":146,"end":147},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T404","span":{"begin":226,"end":227},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T153","span":{"begin":122,"end":131},"obj":"Chemical"},{"id":"T154","span":{"begin":175,"end":196},"obj":"Chemical"},{"id":"T155","span":{"begin":187,"end":196},"obj":"Chemical"},{"id":"T156","span":{"begin":216,"end":237},"obj":"Chemical"},{"id":"T157","span":{"begin":228,"end":237},"obj":"Chemical"}],"attributes":[{"id":"A153","pred":"chebi_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A154","pred":"chebi_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/CHEBI_70821"},{"id":"A155","pred":"chebi_id","subj":"T155","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A156","pred":"chebi_id","subj":"T156","obj":"http://purl.obolibrary.org/obo/CHEBI_64932"},{"id":"A157","pred":"chebi_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T131","span":{"begin":0,"end":247},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"846","span":{"begin":77,"end":82},"obj":"Gene"},{"id":"847","span":{"begin":136,"end":147},"obj":"Gene"},{"id":"848","span":{"begin":175,"end":186},"obj":"Gene"},{"id":"849","span":{"begin":216,"end":227},"obj":"Gene"},{"id":"862","span":{"begin":51,"end":61},"obj":"Species"},{"id":"867","span":{"begin":198,"end":210},"obj":"Chemical"},{"id":"868","span":{"begin":239,"end":245},"obj":"Chemical"},{"id":"869","span":{"begin":69,"end":76},"obj":"CellLine"}],"attributes":[{"id":"A846","pred":"tao:has_database_id","subj":"846","obj":"Gene:59272"},{"id":"A847","pred":"tao:has_database_id","subj":"847","obj":"Gene:1508"},{"id":"A848","pred":"tao:has_database_id","subj":"848","obj":"Gene:1514"},{"id":"A849","pred":"tao:has_database_id","subj":"849","obj":"Gene:1508"},{"id":"A862","pred":"tao:has_database_id","subj":"862","obj":"Tax:2697049"},{"id":"A867","pred":"tao:has_database_id","subj":"867","obj":"MESH:C576116"},{"id":"A868","pred":"tao:has_database_id","subj":"868","obj":"MESH:C068250"},{"id":"A869","pred":"tao:has_database_id","subj":"869","obj":"CVCL:0045"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074)."}